
Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …

The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

